10:34 AM EDT, 08/21/2024 (MT Newswires) -- Healthcare marketplace Sesame said Wednesday that it will offer compounded versions of Novo Nordisk's ( NVO ) weight-loss drug Wegovy to qualified customers for $249 per month as part of its new weight-loss program in the US.

Compounded semaglutide, the active ingredient in Wegovy, will be available to eligible customers "with no retail price markup" amid shortages in branded weight loss and diabetes drugs called GLP-1s, Sesame said.

Price: 134.94, Change: -0.87, Percent Change: -0.64